Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2025-12-25 @ 12:40 AM
NCT ID:
NCT01432067
Eligibility Criteria:
Inclusion Criteria:
* 70 years old or older
* Curative cares for cancer by chemotherapy and/ or surgery and/or hormonotherapy and/ or radiotherapy
* Patient with histologically proven lymphoma or carcinoma :
* Colon, rectum or anal canal Cancer
* Breast Cancer
* Esophageal cancer
* Otolaryngology Cancer
* Kidney cancer
* hepatocellular carcinoma
* Stomach Cancer
* Pancreatic cancer
* Bile duct cancer
* Ovarian Cancer
* All lymphoma diffuse large B-cell and all peripheral T-cells lymphomas
* All low-grade lymphoma: lymphocytes, lymphocytes and plasma cells, follicular, mantle, marginal zone (MALT and others)
* Prostate cancer
* Bladder Cancer
* Lung cancer
* adenocarcinoma of unknown primary origin compatible with previous quoted origin
* Performance status (ECOG) \<4
* Patient who had given oral consent to participate in the study
Exclusion Criteria:
* Palliative cares for cancer
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
70 Years
Study:
NCT01432067
Study Brief:
Protocol Section:
NCT01432067